Provided by Tiger Trade Technology Pte. Ltd.

EVEREST MED

39.720
+0.4601.17%
Volume:247.50K
Turnover:9.80M
Market Cap:14.06B
PE:-12.49
High:39.980
Open:39.380
Low:38.760
Close:39.260
52wk High:77.550
52wk Low:35.540
Shares:354.00M
HK Float Shares:354.00M
Volume Ratio:0.33
T/O Rate:0.07%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-3.180
ROE:-23.04%
ROA:-9.09%
PB:3.16
PE(LYR):-12.49
PS:14.59

Loading ...

Everest Medicines (SEHK:1952) Valuation Check After Recent Share Price Volatility

Simply Wall St.
·
Feb 14

Everest MED Shares Surge Afternoon on New Drug Approval

Stock News
·
Feb 06

Everest Medicines (1952) Secures NMPA Approval for VELSIPITY® in China to Treat Moderately-to-Severely Active Ulcerative Colitis

Bulletin Express
·
Feb 06

EVEREST MED Receives Chinese Approval for VELSIPITY® to Treat Moderate to Severe Ulcerative Colitis

Stock News
·
Feb 06

Everest Medicines - Nmpa China Approves Drug Application for Velsipity for Ulcerative Colitis

THOMSON REUTERS
·
Feb 06

China Approves Everest Medicines' VELSIPITY for Moderately-to-Severely Active Ulcerative Colitis

Reuters
·
Feb 06

Everest Medicines (01952) Publishes January 2026 Monthly Return on Equity Movements

Bulletin Express
·
Feb 05

Everest Medicines Acquires License to Commercialize Kidney Drug MT1013

MT Newswires Live
·
Feb 05

BRIEF-Everest Medicines Inks Agreement With Micot To Commercialize MT1013

Reuters
·
Feb 05

EVEREST MED (01952) Strengthens Renal Portfolio with Global First-in-Class Dual-Target Peptide Drug MT1013

Stock News
·
Feb 05

EVEREST MED Subsidiary Inks Deal with Micot for Commercialization of MT1013 Across Greater China and Asian Markets

Stock News
·
Feb 05

Everest Medicines Ltd - Unit's Payment Obligations Include an Upfront Payment of RMB200 Mln, Others

THOMSON REUTERS
·
Feb 05

Everest Medicines schließt Lizenzvereinbarung mit Micot zur Kommerzialisierung von MT1013 in China und Asien

Reuters
·
Feb 05

Everest Medicines Ltd - Agreement With Micot to Commercialize Mt1013 in Greater China and Other Asian Markets

THOMSON REUTERS
·
Feb 05

Everest Medicines (1952) Announces Extraordinary General Meeting on 24 February 2026

Bulletin Express
·
Feb 03

Everest Medicines (1952) Announces Continuing Connected Transactions, Proposed Connected-Person Award, and 2026 Share Scheme

Bulletin Express
·
Feb 03

Everest Medicines (Stock Code: 1952) Announces Virtual EGM Arrangement for 24 February 2026

Bulletin Express
·
Feb 03

Everest Medicines (1952) Announces Virtual EGM Agenda and Share Schemes

Bulletin Express
·
Feb 03

Everest Medicines gibt Termin für außerordentliche Hauptversammlung bekannt

Reuters
·
Feb 03

Everest Medicines Limited (1952) Announces Book Closure Period for Extraordinary General Meeting

Bulletin Express
·
Feb 02